In our recent observation we confronted with the question.
May β-lactamase inhibitors (Clavulanic acid, Sulbactam, Tazobactam) induce Resistance to β-lactam Antibiotics (penicillins, cefalosporins, carbapenems) in bacteria associated with clinical infections? A new reason for the emergence of AMR. https://www.researchgate.net/publication/325544577_Beta-lactamase_Inhibitors_May_Induce_Resistance_to_Beta-lactam_Antibiotics_in_Bacteria_Associated_with_Clinical_Infections